Royalty Pharma plc - Class A — Quarterly Financial Data (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share 0.210.840.220.220.220.88 1.54 Dividend yield % 5.053.294.754.144.252.28 15.42 Payout ratio % 17.36182.6140314.2932.84179.59 566.71

新闻

TD Cowen relève l’objectif de cours de Royalty Pharma à 50$

TD Cowen raises Royalty Pharma stock price target to $50 on growth

L’action Royalty Pharma atteint un sommet de 52 semaines à 46,14 $

Royalty Pharma stock hits 52-week high at 46.14 USD

Wells Fargo relève l’objectif de cours de Revolution sur les progrès des essais

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

BofA Securities maintient sa recommandation d’achat sur l’action Royalty Pharma avec un objectif de 54€

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

L’action de Royalty Pharma atteint un sommet de 52 semaines à 44,94 USD

Royalty Pharma stock hits 52-week high at 44.94 USD